The Cefazolin Inoculum Effect: An Underappreciated Factor in MSSA Treatment Strategies

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Methicillin-susceptible Staphylococcus aureus (MSSA) causes significant global morbidity and mortality.
• MSSA infections, including bloodstream infections, osteomyelitis, and endocarditis, are more prevalent than methicillin-resistant S. aureus (MRSA).
• Cefazolin is a primary treatment for MSSA due to its safety and cost-effectiveness.

Purpose of the Study:

• To review the molecular basis, clinical relevance, and diagnostic challenges of the cefazolin inoculum effect (CzIE).
• To inform antibiotic stewardship and optimize treatment strategies for serious MSSA infections.

Main Methods:

• Literature review evaluating molecular mechanisms of CzIE.
• Analysis of clinical data and reported prevalence of CzIE.
• Discussion of diagnostic challenges and impact on treatment.

Main Results:

• The cefazolin inoculum effect (CzIE) diminishes cefazolin activity at high bacterial densities.
• CzIE prevalence varies geographically (0-55%) and is not linked to a single genetic determinant.
• Elevated cefazolin minimum inhibitory concentrations (MICs) due to CzIE may lead to treatment failure.

Conclusions:

• CzIE poses a challenge to effective MSSA treatment, potentially increasing mortality.
• Further clinical investigation is needed to fully understand the impact of CzIE on patient outcomes.
• Optimizing diagnostic approaches and treatment strategies for CzIE is crucial for managing serious MSSA infections.